Prevalence of Extended Spectrum β-Lactamase and Antimicrobial Susceptibility Pattern of Clinical Isolates of Pseudomonas from Patients of Khyber Pakhtunkhwa, Pakistan

Table 4

In vitro susceptibility of ESBL and non-ESBL producing Pseudomonas spp. shows the MICs against the tested strain (MIC 50 g/mL and MIC 90 g/mL).

Antibiotics	% susceptibility	MIC 50 g/mL	MIC 90 g/mL
AMC	21.56	16	32
AML	14.97	32	64
SCF	66.17	4	16
CEC	21.26	128	256
CAZ	34.13	64	64
CRO	36	32	128
FEP	48.5	8	32
CIP	46.71	2	16
GTX	52.40	16	128
MXF	58.08	0.5	2
MEM	91.02	1	4
IPM	87.43	1	8
CN	19.16	16	32
AK	67.07	4	4
DO	10.18	256	512